Why FTAI Aviation FTAI cost structure is getting attention FTAI Aviation Q1 Earnings EPS Misses but Revenue Reaches 25B KalVista Pharmaceuticals KALV Stock Increase Exposure Trades Higher 20260418 ARES Ares Management Corporation reports 16 percent Q4 2025 EPS miss but shares gain nearly six percent on positive investor sentiment Agnico Eagle AEM Reports Strong Q1 2026 Revenue NA EPS Beats Oil Price Slumps After Trump Calls Off Iran Attacks Strait of Hormuz Closure Spikes Volatility Danaos DAC Stock Slides 288 Support at 12264 20260515 OFS Credit OCCIN Q1 2026 Disappoints EPS 076 Below 022 Views Record Market Rally Drives Strong Portfolio Gains Over Six Weeks Hassett Hails Record Credit Card Spending Amid Rising Delinquencies and Farm Bankruptcy Surge SpaceX Launches Starship Test Flight on Second Attempt Marking Key Milestone for Private Space Industry Dog Club Treasurer Admits to 20000 Fraud Lessons in Nonprofit Financial Controls SpaceX Eyes Public Markets What Investors Should Know About the Potential IPO SpaceXs Public Debut Raises Sector Classification Question Industrials Tech or Telecommunications RCL Q1 2026 Earnings Strong EPS Beat Drives Market Optimism Gerdau SA GGB Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly CONMED Corporation CNMD Q1 2026 Earnings EPS Beat Amid Margin Improvement HCAT Q1 2026 Earnings Earnings Beat Sentiment but Stock Slips PRCT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher SCIIU Holds Steady at 1018 Consolidating Within Range as SPAC Unit Trades Flat AXIA Energia AXIA Holds Near 1042 After Marginal Decline Eyes Key Support IN8bio Inc INAB Surges Over 8 Breaking Through Key Levels with Strong Momentum Ultra Clean Holdings UCTT Surges 426 as Bulls Test Resistance Near 8821 Rezolute Inc RZLT Slides Amid Sector Pressure Key Levels to Watch Nigel Farages Russian Hack Claim Dismissed as Without Any Merit by Former NCSC Chief Amid Crypto Donation Controversy BUSEP Q1 2026 Earnings EPS Exceeds Estimates by 1316 CytomX Therapeutics CTMX Faces Selling Pressure as Stock Declines 26 Towards Key Support